The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2024

Filed:

Jan. 06, 2021
Applicant:

Vaccinex, Inc., Rochester, NY (US);

Inventors:

Pamela M. Holland, Cambridge, MA (US);

Andrew Lake, Cambridge, MA (US);

Austin Dulak, Cambridge, MA (US);

Ernest Smith, Rochester, NY (US);

Maria Scrivens, Cambridge, MA (US);

Caroline Harvey, Rochester, NY (US);

Renee Kirk, Rochester, NY (US);

Leslie Balch, Rochester, NY (US);

Sonia G. Das, Cambridge, MA (US);

Christopher Converse Wells, Cambridge, MA (US);

Assignee:

Vaccinex Inc., Rochester, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 47/6803 (2017.08); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); C07K 2317/31 (2013.01); C07K 2317/41 (2013.01); C07K 2317/622 (2013.01); C07K 2317/732 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present disclosure is directed to antibodies or antigen-binding portions thereof that specifically bind human CCR8, polynucleotides and vectors encoding the same, and pharmaceutical compositions comprising the same. Some aspects of the disclosure are directed to methods of treating a disease or condition comprising administering the anti-CCR8 antibody to a subject in need thereof.


Find Patent Forward Citations

Loading…